Cite Filings / ACHV / 0002012383-26-002256
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

ACHIEVE LIFE SCIENCES, INC. · Filed 2026-07-27 · Acc 0002012383-26-002256

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-07-29 4 Options or other derivatives
  • 2026-07-29 4 Options or other derivatives
  • 2026-07-29 4 Options or other derivatives
  • 2026-07-28 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-07-27 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-07-08 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Venrock Healthcare Capital Partners III, L.P. 5.2%
  2. 2026-11-16 SCHEDULE 13G/A · Alyeska Investment Group, L.P. 3.22%
  3. 2026-11-16 SCHEDULE 13G/A · Logos Global Management LP 9.99%
  4. 2026-11-16 SCHEDULE 13G/A · Logos Global Management LP 8.6%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…